SCHEMBL24377044

SCHEMBL24377044

c1ccc(-c2ccc3cc(-c4nc(-c5ccc6ccccc6c5)nc(-c5ccc6ccccc6c5-c5ccccc5)n4)ccc3c2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 6/20 0.42
▸ ESR2 Q92731 6/20 0.42
▸ CYP1A2 P05177 2/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ TP53 P04637 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41
▸ GPR84 Q9NQS5 2/20 0.41
▸ CYP17A1 P05093 1/20 0.41
▸ CYP19A1 P11511 1/20 0.41
▸ CYP11B1 P15538 1/20 0.41
▸ CYP11B2 P19099 1/20 0.41
▸ HSD17B1 P14061 2/20 0.39
▸ HSD17B2 P37059 2/20 0.39
▸ CYP1A1 P04798 1/20 0.39
▸ CYP1B1 Q16678 1/20 0.39
▸ CYP3A4 P08684 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23633497 0.97 SMN1; SMN2 (0.43) ESR1ESR2CYP1A2KDM4EMEN1
SCHEMBL23633716 0.95 SMN1; SMN2 (0.45) ESR1ESR2CYP1A2KDM4EMEN1
SCHEMBL23633668 0.94 HSD17B1 (0.41) ESR1ESR2CYP1A2KDM4EMEN1
SCHEMBL26606223 0.92 ESR1 (0.39) ESR1ESR2CYP1A2KDM4EMEN1
SCHEMBL21477854 0.91 SMN1; SMN2 (0.44) ESR1ESR2CYP1A2KDM4EMEN1
SCHEMBL23633556 0.91 SMN1; SMN2 (0.46) ESR1ESR2CYP1A2KDM4EMEN1
SCHEMBL24377132 0.91 GPR84 (0.46) ESR1ESR2CYP1A2KDM4EMEN1
SCHEMBL25816530 0.91 CA12 (0.44) ESR1ESR2CYP1A2KDM4EMEN1
SCHEMBL24377403 0.90 GPR84 (0.39) ESR1ESR2CYP1A2KDM4EMEN1
SCHEMBL18819274 0.90 MEN1 (0.49) CYP1A2KDM4EMEN1ALDH1A1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220131082-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2022-04-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220131082-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF NFE2L2, OR51E2, ETV6 ESR1 5/4885ESR2 79/4885CYP1A2 2551/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback